The group is currently studying the neuronal regeneration effect of the drug Nucleo CMP-Forte in co-cultures of Schwann cells and neurons. Since 2007, the group has been researching the effect of the same drug on Schwann cells in the treatment of peripheral neuropathies and the regeneration of the peripheral nervous system. Conclusion: Nucleo CMP Forte in combination with ES contributes to a more pronounced regression of patients' complaints, clinical manifestations, severity, and neurophysiological indicators in mild-to-moderate CTS. From 2003 to 2006, the effect of the drug Nucleo CMP-Forte on nerve cells was studied. The collaboration has continued for 13 years.įrom 1999 to 2002, the protective effects of the drug Citicolina on neuronal cell death was studied.
Núria Casals, began in 1999 with a scientific collaboration with Ferrer to study the action mechanism of different drugs. M09AX - Other drugs for disorders of the musculo-skeletal system. M09A - Other drugs for disorders of the musculo-skeletal system. The Pharmacology Area of the UIC Faculty of Medicine and Health Sciences, directed by Dr. M09 - Other drugs for disorders of the musculo-skeletal system. Núria Casals, the Head of the Nucleo CMP-Forte Ferrer Programme, attended the signing. Albert Balaguer, the Dean of the Faculty of Medicine and Health Sciences and Dr. Lorenzo, the Medical Director were present at the signing of the agreement. Joaquim Delgadillo, the Director of Clinical Development and Dr. Fernando García Alonso, the Director of the Scientific Area Dr.
0 kommentar(er)
